{"id":16969,"date":"2026-06-09T10:40:39","date_gmt":"2026-06-09T13:40:39","guid":{"rendered":"https:\/\/www.brainn.org.br\/?p=16969"},"modified":"2026-06-16T09:41:30","modified_gmt":"2026-06-16T12:41:30","slug":"medicina-de-precisao-para-todos-conheca-a-the-lancet-commission-on-precision-health","status":"publish","type":"post","link":"https:\/\/www.brainn.org.br\/en\/medicina-de-precisao-para-todos-conheca-a-the-lancet-commission-on-precision-health\/","title":{"rendered":"Precision medicine for all: an introduction to The Lancet Commission on Precision Health"},"content":{"rendered":"<em>The initiative includes BRAINN researcher Iscia Lopes\u2011Cendes and aims to expand the reach of precision medicine within a complex global socioeconomic landscape.<\/em><\/p>\n<p><!--more--><\/p>\n<p>&nbsp;<\/p>\n<p><em><strong><a href=\"https:\/\/www.brainn.org.br\/annual-reviews-como-integrar-genomica-medicina-de-precisao-e-sistemas-de-saude-na-america-latina\/\"><span style=\"text-decoration: underline;\">Precision medicine<\/span><\/a> for all<\/strong><\/em> \u2014 this is the objective of a new global initiative that seeks to broaden the scope of <em>precision health<\/em> (a term encompassing both disease prevention and treatment), deploying cutting\u2011edge technologies across diverse socioeconomic contexts.<\/p>\n<p>The The Lancet Commission on Precision Health, of which CEPID BRAINN researcher Dr. <span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.brainn.org.br\/grupo-consultivo-tecnico-sobre-genomica-tag-g-da-oms-presidido-pela-pesquisadora-iscia-lopes-cendes-publica-artigo-na-nature-medicine\/\"><strong>Iscia Lopes\u2011Cendes<\/strong><\/a><\/span> is a member, intends to translate medical, scientific, technological and analytical advances into effective, equitable and financially sustainable health interventions that account for the social, cultural and economic characteristics of specific populations. This is precision medicine in practice, tested in real\u2011world settings. Below is a summary of the project.<\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>See also<\/strong><\/em><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"y1hyZ9sMa7\"><p><a href=\"https:\/\/www.brainn.org.br\/annual-reviews-como-integrar-genomica-medicina-de-precisao-e-sistemas-de-saude-na-america-latina\/\">Annual Reviews: como integrar Gen\u00f4mica, Medicina de Precis\u00e3o e sistemas de sa\u00fade na Am\u00e9rica Latina?<\/a><\/p><\/blockquote>\n<p><iframe class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; clip: rect(1px, 1px, 1px, 1px);\" title=\"&#8220;Annual Reviews: como integrar Gen\u00f4mica, Medicina de Precis\u00e3o e sistemas de sa\u00fade na Am\u00e9rica Latina?&#8221; &#8212; CEPID BRAINN\" src=\"https:\/\/www.brainn.org.br\/annual-reviews-como-integrar-genomica-medicina-de-precisao-e-sistemas-de-saude-na-america-latina\/embed\/#?secret=y1hyZ9sMa7\" data-secret=\"y1hyZ9sMa7\" width=\"500\" height=\"282\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>The era of one\u2011size\u2011fits\u2011all treatment is over<\/strong><\/h2>\n<p>Many of the world\u2019s most common and serious diseases (such as cardiovascular disease, mental health disorders and cancer) do not affect all individuals in the same way. Disease etiology and treatment responses can vary substantially between individuals and across populations. Nevertheless, most health systems still employ a <em>one\u2011size\u2011fits\u2011all<\/em> approach, which constrains therapeutic efficacy and the equity of care.<\/p>\n<p>According to researchers from The Lancet Commission, this unified approach to disease management made sense until recently, prior to the major medical, technological and data\u2011processing advances of the last decades.<\/p>\n<p>\u201cMost modern healthcare is based on population averages \u2014 adopting an approach that assumes what works on average will work for each individual,\u201d the group states.<\/p>\n<blockquote><p>\u201cThis \u2018one\u2011size\u2011fits\u2011all\u2019 model was reasonable when we lacked tools to predict disease risk or treatment response with precision. Today, however, we know that people differ markedly in how diseases develop and how treatments perform, depending on their genetics, environment, behavior and access to healthcare.\u201d<\/p><\/blockquote>\n<p>&nbsp;<\/p>\n<h2><strong>About the Commission<\/strong><\/h2>\n<p>The The Lancet Commission on Precision Health aims to change this paradigm by developing prevention and care strategies that make healthcare more effective and equitable worldwide. The group\u2019s stated goal is \u201cto ensure that the benefits of precision medicine reach all populations, not only a privileged few.\u201d<\/p>\n<div id=\"attachment_16977\" style=\"width: 2457px\" class=\"wp-caption aligncenter\"><img aria-describedby=\"caption-attachment-16977\" loading=\"lazy\" class=\"wp-image-16977 size-full\" src=\"https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1.jpg\" alt=\"The Lancet Commission on Precision Health - Figure 1\" width=\"2447\" height=\"1167\" srcset=\"https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1.jpg 2447w, https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-300x143.jpg 300w, https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-1024x488.jpg 1024w, https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-768x366.jpg 768w, https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-1536x733.jpg 1536w, https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-2048x977.jpg 2048w, https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-419x200.jpg 419w, https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-82x39.jpg 82w, https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-100x48.jpg 100w, https:\/\/www.brainn.org.br\/wp-content\/uploads\/2026\/06\/The-Lancet-Comission-on-Precision-Health-Figure-1-Comment-1-156x74.jpg 156w\" sizes=\"(max-width: 2447px) 100vw, 2447px\" \/><p id=\"caption-attachment-16977\" class=\"wp-caption-text\"><em>Working model of the Commission for precision health studies. Source: <a href=\"https:\/\/www.theprecisionhealthcommission.org\/about\/\" target=\"_blank\" rel=\"noopener\">official website<\/a> of the group<\/em><\/p><\/div>\n<p>&nbsp;<\/p>\n<p>Precision\u2011based strategies have already been implemented successfully in high\u2011income countries using advanced (and costly) technologies, particularly in oncology. The Commission seeks to demonstrate that these examples do not exhaust the potential of this medical\u2011scientific approach, which can also be adopted in settings with greater economic and technological constraints. In other words, there are accessible, low\u2011cost opportunities that can help scale precision medicine globally.<\/p>\n<blockquote><p><em>Precision Health considers an individual\u2019s genetic, biological and environmental characteristics to design tailored therapeutic strategies. This enables improvements in treatment duration and effectiveness, as well as in preventive measures.<\/em><\/p><\/blockquote>\n<p>The group will examine the application of precision health both for disease prevention (through lifestyle changes, behavioral interventions and pharmacotherapies) and for disease management (including diagnostics, therapies, prognostics and monitoring), comparing health outcomes and quality of life of subgroups and individuals against traditional standardized treatments.<\/p>\n<p>The Commission comprises more than 20 researchers from around the world. Latin America is represented by CEPID BRAINN physician\u2011researcher Dr. Iscia Lopes\u2011Cendes, an expert in genomic medicine and multi\u2011omics technologies applied to neuroscience, and by Dr. Christian Kieling from the Federal University of Rio Grande do Sul.<\/p>\n<p>The Commission will operate for approximately three years, having been formally launched in January 2026. The group\u2019s studies, analyses, findings and recommendations will be published periodically in The Lancet, one of the world\u2019s leading scientific journals.<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>For further reading<\/strong><\/h3>\n<p>For more details and information, consult the official launch announcement in The Lancet and the links below.<\/p>\n<ul>\n<li>Franks PW, Lim LL, Ramsay M, Chotirmall SH, Abedalthagafi MS, Ali R, K SB, Ford J, Giordano GN, Hamdi Y, Kieling C, Leal J, Li F, Lopes\u2011Cendes I, Lyons L, Misra S, Owolabi MO, Rosenquist R, Tandon N, Tsosie KS, Udler MS, Smeden MV, Verguet S, Wason J. The Lancet Commission on precision health: equitable, data\u2011driven health outcomes for all. Lancet. 2026 May 25:S0140-6736(26)00612-4. doi: 10.1016\/S0140-6736(26)00612-4. Epub ahead of print. PMID: 42184810.<\/li>\n<li>See the Commission\u2019s publications list: <span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.theprecisionhealthcommission.org\/publications\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.theprecisionhealthcommission.org\/publications\/<\/a><\/span><\/li>\n<li>Visit the official website: <span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.theprecisionhealthcommission.org\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.theprecisionhealthcommission.org\/<\/a><\/span><\/li>\n<\/ul>\n<p>&nbsp;","protected":false},"excerpt":{"rendered":"<p>Sorry, this entry is only available in Brazilian Portuguese.<\/p>\n","protected":false},"author":13,"featured_media":16976,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pgc_meta":""},"categories":[550],"tags":[666,1035,1036,1037],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/posts\/16969"}],"collection":[{"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/comments?post=16969"}],"version-history":[{"count":1,"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/posts\/16969\/revisions"}],"predecessor-version":[{"id":16983,"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/posts\/16969\/revisions\/16983"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/media\/16976"}],"wp:attachment":[{"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/media?parent=16969"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/categories?post=16969"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.brainn.org.br\/en\/wp-json\/wp\/v2\/tags?post=16969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}